ATAP Letter to Congressional Leaders on Biosimilar Red Tape Elimination Act (S. 2305) Dan ReneNovember 5, 2024
ATAP’s Dr. Angus Worthing Testifies to Maryland House of Delegates to Support HB 1270 Dan ReneFebruary 29, 2024
Dr. Robert Levin South Florida Sun Sentinel Op-Ed: Addressing the real culprits of rising drug prices Dan ReneJanuary 7, 2024
Maximizing Patient Access: ATAP Action Network's Recommendations for Medicare Drug Price Negotiation Program Dan ReneOctober 2, 2023
Inside Sources Commentary: Unshackling Drug Prices From Pharmacy Benefit Managers Dan ReneSeptember 24, 2023
